TX HLTH HARRIS METHODIST AZLE — History
CCN 450419 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$50M
Latest Revenue (FY2022)
+21.0%
Revenue CAGR (3yr)
13.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $34M | $45M | $50M | +11.0% | +21.0% |
| Operating Expenses | $34M | $40M | $43M | +9.3% | +12.2% |
| Operating Margin | -0.2% | 12.4% | 13.7% | +10.8% | +0.0% |
| Net Income | $-0M | $6M | $7M | +23.0% | +0.0% |
| Licensed Beds | 31 | 31 | 31 | +0.0% | +0.0% |
| Total Patient Days | 3,632 | 6,539 | 5,848 | -10.6% | +26.9% |
| Medicare Day % | 28% | 22% | 24% | +10.7% | -6.3% |
| Medicaid Day % | 0% | 0% | 1% | +1055.4% | +79.1% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +46.3% ($34M → $50M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+21.0%
This Hospital
+7.6%
State Avg
Latest Margin
13.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $58M | 20.7% |
| FY2024 (proj) | $66M | 27.6% |
| FY2025 (proj) | $74M | 34.6% |